You are here

Article info

Article menu
Download PDFPDF
Review
Letrozole in the management of advanced ovarian cancer: an old drug as a new targeted therapy

Authors

  • Claudia Marchetti Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy PubMed articlesGoogle scholar articles
  • Francesca De Felice Department of Radiological, Oncological and Anatomo Pathological Sciences, Azienda Policlinico Umberto I; Sapienza University of Rome, Rome, Italy PubMed articlesGoogle scholar articles
  • Raffaella Ergasti Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy PubMed articlesGoogle scholar articles
  • Giovanni Scambia Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy Catholic University Sacred Heart, Rome, Italy PubMed articlesGoogle scholar articles
  • Anna Fagotti Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy Catholic University Sacred Heart, Rome, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Giovanni Scambia, Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma 00168, Italy; giovanni.scambia{at}policlinicogemelli.it
View Full Text

Citation

Marchetti C, De Felice F, Ergasti R, et al
Letrozole in the management of advanced ovarian cancer: an old drug as a new targeted therapy
International Journal of Gynecologic Cancer 2020;30:1058-1064.

Publication history

  • Received December 4, 2019
  • Revision received January 20, 2020
  • Accepted January 27, 2020
  • First published March 26, 2020.
Online issue publication 
July 06, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.